Can Nasal Spray Cause Heart Palpitations?

Certain nasal sprays can cause heart palpitations, but the risk depends almost entirely on which type you use. Decongestant nasal sprays containing drugs like oxymetazoline, phenylephrine, or xylometazoline work by mimicking part of the body’s adrenaline system, and that mechanism can speed up or destabilize heart rhythm in some people. Not every nasal spray carries this risk, though. Steroid sprays, saline rinses, and antihistamine sprays operate through completely different pathways and have no meaningful effect on heart rate.

How Decongestant Sprays Affect the Heart

The active ingredients in most over-the-counter decongestant sprays belong to a class of drugs called sympathomimetics. That means they mimic the sympathetic nervous system, the same system responsible for your fight-or-flight response. When you spray them into your nose, they bind to receptors on blood vessel walls and shrink swollen tissue, which is why your nose opens up almost immediately. The problem is that those same receptors exist throughout the body, including in the heart and blood vessels.

These drugs stimulate receptors that increase heart rate, strengthen the force of each heartbeat, and speed up electrical conduction through cardiac tissue.¹ In most healthy people using the recommended dose for a few days, the amount of drug absorbed through the nasal lining is small enough that these cardiac effects are negligible. But the margin of safety narrows quickly with overuse, prolonged use, or in people whose hearts are already sensitive to stimulation.

Which Nasal Sprays Carry the Risk

The distinction that matters most is whether the spray contains a decongestant or not. This trips people up because “nasal spray” covers a wide range of products that work in fundamentally different ways.

• Decongestant sprays: Products containing oxymetazoline (Afrin, Vicks Sinex), phenylephrine, xylometazoline, or tramazoline are the ones linked to cardiac effects. They constrict blood vessels to relieve stuffiness and are the category implicated in palpitations, elevated blood pressure, and rhythm disturbances.
• Corticosteroid sprays: Fluticasone (Flonase), mometasone (Nasonex), budesonide (Rhinocort), and similar products reduce inflammation over days to weeks. They do not act on the sympathetic nervous system and are not associated with heart palpitations.
• Antihistamine sprays: Azelastine (Astelin) and olopatadine (Patanase) block histamine in the nasal passages. They do not stimulate cardiac receptors.
• Saline sprays and rinses: These are just salt water. No active drug, no cardiac risk.

A narrative review of clinical evidence on sympathomimetic decongestants specifically recommended that patients be educated about the cardiovascular risks of these products and encouraged toward safer alternatives like intranasal corticosteroids or saline sprays when appropriate.² If you have been using a steroid spray or saline rinse and noticed palpitations, the spray is almost certainly not the cause, and it is worth looking at other factors like caffeine, stress, or an underlying arrhythmia.

Documented Cases of Serious Heart Rhythm Problems

Most of the published clinical evidence linking nasal decongestant sprays to cardiac events involves people who used them excessively or for far longer than recommended. A case report in the Mayo Clinic Proceedings described a 60-year-old woman who developed atrial fibrillation with a heart rate of 100 beats per minute after years of using a topical decongestant containing tramazoline to treat chronic sinusitis. She had been applying it up to five times a day during flare-ups. Remarkably, three weeks after her treatment, her 62-year-old husband arrived at the same clinic with atrial fibrillation and an almost identical pattern of long-term decongestant overuse.³

In a more extreme scenario, a 32-year-old woman undergoing sinus surgery developed ventricular tachycardia after adrenaline-soaked pledgets were placed inside her nose during the procedure. Ventricular tachycardia is a fast, dangerous heart rhythm originating from the lower chambers of the heart, and in this case it required defibrillation to correct.⁴ This is a surgical setting using adrenaline directly, not a typical consumer spray, but it illustrates just how efficiently the nasal lining can absorb drugs into the bloodstream.

These cases are unusual, and that is partly the point. Most people who follow the label and use a decongestant spray for three to five days do not end up with arrhythmias. The risk climbs when usage stretches into weeks, months, or years, and when the number of daily applications creeps above what is recommended.

The Overuse Trap and Why It Matters for the Heart

Decongestant nasal sprays are supposed to be short-term tools, generally three consecutive days or fewer. When people use them longer, the nasal tissue adapts and begins to swell more aggressively as each dose wears off. This rebound congestion, sometimes called rhinitis medicamentosa, pushes people to spray more often and in higher amounts just to breathe normally. The congestion feels worse than it did before they started the spray, which drives even heavier use.

This cycle is directly relevant to cardiac risk because the total amount of drug absorbed rises with each extra application. An animal study on oxymetazoline found that the drug produced significant tissue-level changes outside the nose, including ischemic changes and increased congestion in cardiac tissue, when compared to controls.⁵ While animal findings do not transfer directly to humans, they offer a plausible explanation for why chronic overuse could affect heart function: the drug is not staying in the nose.

If you find yourself reaching for a decongestant spray multiple times a day for weeks on end, you are both worsening your nasal congestion and increasing systemic drug exposure. Breaking the cycle usually involves switching to a corticosteroid spray, which treats the underlying inflammation without the rebound effect, sometimes with a brief course of oral steroids to get through the worst of the withdrawal congestion.

Drug Interactions That Raise the Stakes

Decongestant sprays do not exist in a vacuum, and certain medications can amplify their cardiovascular effects significantly. The most dangerous interaction involves monoamine oxidase inhibitors, a class of antidepressants. MAOIs block the enzyme that normally breaks down adrenaline-like chemicals in the body. When someone on an MAOI uses a sympathomimetic decongestant spray, the adrenaline-mimicking drug persists longer and at higher levels than it would otherwise. Both phenylephrine and oxymetazoline are specifically flagged as drugs that patients on MAOIs should avoid because of the risk of dangerous blood pressure spikes.⁶

MAOIs are less commonly prescribed today than they once were, but they are still used for treatment-resistant depression and certain other conditions. People taking them are usually warned about dietary and drug restrictions, but the warning about nasal sprays is easy to miss because most people think of these products as harmless. Other medications that can interact include stimulants prescribed for ADHD, certain migraine treatments, and other sympathomimetic drugs. Using a decongestant spray while also taking an oral decongestant, for instance, roughly doubles the sympathomimetic load on the heart.

Who Is Most Vulnerable

The cardiac effects of decongestant sprays are not distributed equally. Several groups face higher risk, and it is worth knowing who they are because some of these groups are also the people most likely to reach for a nasal spray in the first place.

Older adults are a major concern. Age-related changes in the cardiovascular system and in how drugs are metabolized mean that the same dose of oxymetazoline produces a stronger and longer-lasting effect in a 75-year-old than in a 30-year-old. A review of rhinitis treatment in the elderly noted that over-the-counter decongestants frequently result in cardiovascular adverse effects in this population, and that topical therapies like corticosteroids and ipratropium bromide are better tolerated with minimal side effects.⁷ The same review pointed out that some older antihistamines can also cause electrocardiographic changes, including QT prolongation, which is a separate cardiac concern.

People with existing heart conditions, including high blood pressure, coronary artery disease, or a history of arrhythmias, are also at elevated risk. Their hearts are already working under strain or have altered electrical pathways, and adding a sympathomimetic stimulus on top of that can push things over a threshold. The married couple in the Mayo Clinic case report were both in their sixties with chronic sinusitis and no previously diagnosed heart disease, which suggests that prolonged decongestant overuse can create cardiac problems even in people who seem otherwise healthy.

People with hyperthyroidism should be cautious as well. An overactive thyroid already increases heart rate and the heart’s sensitivity to adrenaline-like stimulation. Layering a sympathomimetic decongestant on top of that creates a compounding effect that can trigger noticeable palpitations even at standard doses.

When Palpitations from a Nasal Spray Warrant Medical Attention

Occasional extra heartbeats that last a few seconds and resolve on their own are common in the general population, with or without nasal sprays. Not every flutter in your chest after using Afrin means something is wrong. But there are situations where palpitations should prompt a call to your doctor or a trip to urgent care.

Sustained palpitations lasting more than a few minutes, palpitations accompanied by dizziness or lightheadedness, chest pain, or shortness of breath, and palpitations that recur every time you use a decongestant spray all warrant evaluation. A clinical guideline on palpitation workup in primary care specifically notes that a history of all prescription and over-the-counter medications, including nasal decongestants, should be obtained when evaluating a patient with palpitations.⁸ This means your doctor should be asking about nasal sprays, but if they do not, bring it up yourself. Many people forget to mention over-the-counter products because they do not think of them as “real” medications.

If you have been using a decongestant spray for weeks or months and have noticed palpitations developing gradually, mention the full duration and frequency of use. The pattern of escalating use over time, characteristic of rebound congestion, is clinically meaningful and may change how your doctor interprets the symptoms.

Safer Alternatives for Ongoing Congestion

If you deal with chronic nasal congestion from allergies, sinusitis, or other causes, managing it without decongestant sprays is not just possible but usually more effective in the long run. Decongestant sprays are designed for acute, short-lived congestion. They are not built to be daily maintenance drugs, and their rebound effect makes them actively counterproductive when used that way.

Intranasal corticosteroid sprays are the standard first-line treatment for allergic rhinitis and many forms of chronic congestion. They reduce inflammation in the nasal passages over a period of days to weeks and can be used safely for months or even years. They do not constrict blood vessels, do not stimulate the heart, and do not cause rebound congestion. For many people, they provide better congestion relief than decongestant sprays once they have had a week or so to take full effect.

Saline irrigation, either with a squeeze bottle or a neti pot, physically washes mucus, allergens, and irritants out of the nasal passages. It has no drug interactions and no cardiovascular effects whatsoever. It can be used alongside a steroid spray for added relief. Antihistamine sprays like azelastine are another option, particularly for people whose congestion is driven by allergic inflammation. These work within minutes, faster than steroid sprays, and do not carry cardiac risks.

For people already caught in the rebound-congestion cycle, the transition off decongestant sprays can be genuinely uncomfortable for a few days. Some clinicians recommend stopping the decongestant spray in one nostril at a time, using a corticosteroid spray in the cleared nostril while continuing the decongestant in the other, and then switching over completely once the first nostril has recovered. Others prefer a clean break with short-term oral corticosteroids to manage the worst of the swelling. Either way, the discomfort is temporary, and the nasal tissues typically recover within one to three weeks.

Preservatives and Other Inactive Ingredients

Beyond the active decongestant, some nasal sprays contain preservatives that have raised separate health concerns, though these are not directly linked to palpitations. Benzalkonium chloride is an antimicrobial preservative found in many nasal spray formulations, including some corticosteroid sprays. Research has shown that it can impair mucociliary transport, the mechanism by which your nasal lining moves mucus and trapped particles toward the throat.⁹ Impaired mucociliary clearance can worsen congestion over time, potentially pushing a user to add a decongestant spray on top of their regular spray, which indirectly raises the cardiac risk profile.

Some nasal spray brands now offer preservative-free formulations. If you are using a steroid or saline spray daily for chronic management, a preservative-free version may be worth seeking out, not because of heart concerns but because it reduces the chance of irritation that could complicate your congestion management and tempt you back toward decongestants.